91553-67-2

Upstream product

• 31952-01-9 3-benzyl-2-methylperhydro-1,3-oxazine 
• 4720-29-0 3-(benzylamino)propan-1-ol 
• 14321-27-8 N-ethylbenzylamine 
• 1094629-96-5 ethyl 3-(benzyl(ethyl)amino)propanoate 
• 74-96-4 ethyl bromide 

Downstream Products

• 1241383-30-1 C₃₂H₅₂N₄O₂ 
• 1241383-31-2 C₂₉H₄₅N₃O₄S 
• 1241383-32-3 C₂₂H₃₉N₃O₄S 
• 1241383-34-5 C₃₁H₄₉N₃O₆S₂ 
• 1241383-35-6 C₃₈H₅₈N₄O₄S₂ 
• 1241383-36-7 C₅₀H₇₅N₅O₄S₂ 
• 1241383-38-9 C₃₅H₆₂N₄O₆ 
• 1241383-27-6 CH₃O₃S^(1-)*C₁₂H₁₈N⁽¹⁺⁾ 
• 1241383-28-7 C₂₀H₃₅N₃O₂ 
• 742686-12-0 1-amino-4-[N-(2-mesitylene)sulfonyl]-7-{N-ethyl-N-[(2-mesitylene)sulfonyl]}amino-4-azaheptane 
• 1241383-25-4 C₁₃H₂₁NO₃S 

Relevant academic research and scientific papers

Bisethylnorspermine lipopolyamine as potential delivery vector for combination drug/gene anticancer therapies

Purpose: To design novel synthetic gene delivery system in which the carrier molecule functions dually as a carrier and a cytotoxic agent targeting dysregulated polyamine metabolism in cancer. Methods: Bisethylnorspermine (BENSpm) lipopolyamine was synthe

Regioselective Reductive Ring Cleavage of 3-Benzyltetrahydro-1,3-oxazines to 3-Dialkylaminopropanols and of 3-Benzyl-3-methyltetrahydro-1,3-oxazinium Iodides to Alkyl 3-Dialkylaminopropyl Ethers

3-Benzyltetrahydro-1,3-oxazines and their methiodides are ring-cleaved upon reduction with lithium aluminum hydride to give 3-dialkylaminopropanols or alkyl 3-dialkylaminopropyl ethers, respectively, in good yields.The reducing agent regioselectively clea